Abstract
In 2015, the World Health Organization introduced the concept of intrinsic capacity (IC), a composite of all the physical and mental attributes that contribute to healthy aging. While substantial evidence supports the biological basis of IC and its subdomains, the extent of genetic influence on IC remains largely unexplored, with no studies currently available. Understanding the genetic basis of IC is crucial to advancing our knowledge and identifying interventions that promote healthy aging. To investigate the genetic basis of IC, we used data from the UK Biobank (UKB; N=44,631) and the Canadian longitudinal study on aging (CLSA; N=13,085). We estimated SNP-based heritability (h2SNP) at 25.2% in UKB and 19.5% in CLSA. A Genome-Wide Association Study (GWAS) identified 38 independent SNPs for IC across 10 genomic loci and 4,289 candidate SNPs, mapped to 197 genes. Post-GWAS analysis revealed the role of these genes on cellular processes such as cell proliferation, immune function, metabolism, and neurodegeneration, with high expressions in muscle, heart, brain, adipose, and tibial nerve tissues. Of the 52 traits tested, 23 showed significant genetic correlations with IC, and a higher genetic loading for IC was associated with higher IC scores. This study is the first to identify genetic variants and pathways associated with IC, providing a foundation for future research on healthy aging.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Health and Medical Research Council (NHMRC) Emerging Leadership (EL1) Investigator Grant (APP2008000).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The revision was mainly made to add some components to the manuscript because of the publication and promotion policy of one of the data sets we used (CLSA). We added some acknowledgments, data access numbers, and versions and, of course, revised the author's list.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
